Clinical Trial Detail

NCT ID NCT03983993
Title Niraparib and Panitumumab in Patients With Advanced or Metastatic Colorectal Cancer (NIPAVect)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Emory University
Indications

colorectal cancer

Therapies

Niraparib + Panitumumab

Age Groups: adult senior

Additional content available in CKB BOOST